1-12 of 12
Robert Schlossman, M.D.
Close
Sort by
Journal Articles

Combination of Proteasome Inhibitors Bortezomib and NPI-0052 Trigger In Vivo Synergistic Cytotoxicity in Multiple Myeloma.

Dharminder Chauhan, PhD, Ajita Singh, Ph.D, Mohan Brahmandam, M.S, Klaus Podar, Ph.D, Teru Hideshima, M.D., Robert Schlossman, M.D., Paul Richardson, M.D., Nikhil Munshi, M.D., Michael Palladino, Ph.D, Kenneth C. Anderson, M.D.
Journal: Blood
Blood (2007) 110 (11): 2524.
https://doi.org/10.1182/blood.V110.11.2524.2524
Published: 2007
Journal Articles

Acquisition of New In Vivo Genomic Change over Time in Multiple Myeloma.

Yu-Tzu Tai, PhD, Leutz Buon, M.S., Benjamin King, B.S., Cheng Li Cheng Li, Ph.D., Peter Burger Peter Burger, B.S., Xian-Feng Li, M.S., Weihua Song, M.D., Robert Schlossman, M.D., Paul Richardson, M.D., Kenneth C. Anderson, M.D., Nikhil Munshi, M.D.
Journal: Blood
Blood (2007) 110 (11): 2481.
https://doi.org/10.1182/blood.V110.11.2481.2481
Published: 2007
Journal Articles

Genomic Evolution of Multiple Myeloma In Vivo over Time.

Yu-Tzu Tai, PhD, Benjamin King, B.S., Cheng Li, Ph.D., XianFeng Li, M.S., Peter Burger, B.S., Weihua Song, M.D., Masood Shammas, Ph.D., Robert Schlossman, M.D., Paul Richardson, M.D., Kenneth C. Anderson, M.D., Nikhil C. Munshi, M.D.
Journal: Blood
Blood (2006) 108 (11): 3400.
https://doi.org/10.1182/blood.V108.11.3400.3400
Published: 2006
Journal Articles

The BAFF Inhibitor AMG523 Blocks Adhesion and Survival of Human Multiple Myeloma Cells in the Bone Marrow Microenvironment: Clinical Implication.

Yu-Tzu Tai, PhD, Jiangchun Xu, M.D., Xian-Feng Li, M.S., Iris Breitkreutz, M.D., Klaus Podar, M.D. Ph.D., Teru Hideshima, M.D. Ph.D., Robert Schlossman, M.D., Paul Richardson, M.D., Nikhil C. Munshi, M.D., Kenneth C. Anderson, M.D.
Journal: Blood
Blood (2006) 108 (11): 3452.
https://doi.org/10.1182/blood.V108.11.3452.3452
Published: 2006
Journal Articles

Inhibition of ERK1/2 Activity by the MEK1/2 Inhibitor AZD6244 (ARRY-142886) Induces Human Multiple Myeloma Cell Apoptosis in the Bone Marrow Microenvironment: A New Therapeutic Strategy for MM.

Yu-Tzu Tai, PhD, Xian-Feng Li, M.S., Iris Breitkreutz, M.D., Weihua Song, M.D., Peter Burger, B.S., Matthew Rumizen, Teru Hideshima, M.D. Ph.D., Klaus Podar, M.D. Ph.D., Irene Ghobrial, M.D., Robert Schlossman, M.D., Paul Richardson, M.D., Nikhil C. Munshi, M.D., Kenneth C. Anderson, M.D.
Journal: Blood
Blood (2006) 108 (11): 3460.
https://doi.org/10.1182/blood.V108.11.3460.3460
Published: 2006
Journal Articles

Killing of Drug-Sensitive and Resistant Myeloma Cells and Disruption of Their Bone Marrow Stromal Interaction by HuLuc63, a Novel Humanized Anti-CS1 Monoclonal Antibody.

Yu-Tzu Tai, PhD, Weihua Song, M.D., Xian-Feng Li, M.S., Peter Burger, B.S., Robert Schlossman, M.D., Audie Rice, Ph.D., Anne van Abbema, Ph.D., Paul Richardson, M.D., Nikhil C. Munshi, M.D., Daniel Afar, Ph.D., Kenneth C. Anderson, M.D.
Journal: Blood
Blood (2006) 108 (11): 3470.
https://doi.org/10.1182/blood.V108.11.3470.3470
Published: 2006
Journal Articles

Expression and Modulation of Carbohydrate-Binding Protein Galectin-3 in Multiple Myeloma Cells by Combined Treatment with GCS-100 and Dexamethasone.

Dharminder Chauhan, PhD, Yan Chang, Ph.D, Deli He, M.S, Teru Hideshima, MD, Ph.D, Klaus Podar, M.D, Florence Tao, Ph.D, Paola Neri, M.D, Robert Schlossman, M.D, Joanne Schindler, M.D, Bradley Carver, M.D, Paul Richardson, M.D, Kenneth C. Anderson, M.D
Journal: Blood
Blood (2005) 106 (11): 4447.
https://doi.org/10.1182/blood.V106.11.4447.4447
Published: 2005
Journal Articles

Targeting Therapy for Resistant Multiple Myeloma with a Novel Inhibitor of NF-KB, NPI-1387.

Dharminder Chauhan, PhD, Ta-Hsiang Chao, Ph.D, Deli He, M.S, Teru Hideshima, Ph.D, Laurence Catley, M.D, Young-Ger Suh, Ph.D, Robert Schlossman, M.D, Saskia Neuteboom, Ph.D, Michael A. Palladino, Ph.D, Kenneth C. Anderson, M.D.
Journal: Blood
Blood (2005) 106 (11): 640.
https://doi.org/10.1182/blood.V106.11.640.640
Published: 2005
Journal Articles

Targeting Bcl-2 as Therapy for Multiple Myeloma.

Dharminder Chauhan, PhD, Mugdha Velankar, M.S, Teru Hideshima, Ph.D, Constantine Mitsiades, Ph.D, Laurence Catley, M.D, Noopur Raje, M.D, Robert Schlossman, M.D, Paul Richardson, M.D, Kenneth C. Anderson, M.D.
Journal: Blood
Blood (2005) 106 (11): 109.
https://doi.org/10.1182/blood.V106.11.109.109
Published: 2005
Journal Articles

A Fully Human Antagonist Anti-CD40 Antibody Triggers Significant Antitumor Activity Against Human Multiple Myeloma.

Yu-Tzu Tai, Ph.D., Xian-Feng Li, M.S., Xia Tong2, M.S., Laurence Catley, M.D., Daniel Santos, M.D., Olivier Tournilhac, M.D., Ph.D., Robert Schlossman, M.D., Paul Richardson, M.D., Nikhil C. Munshi, M.D., Mohammad Luqman2, Ph.D., Kenneth C. Anderson, M.D.
Journal: Blood
Blood (2004) 104 (11): 2414.
https://doi.org/10.1182/blood.V104.11.2414.2414
Published: 2004
Journal Articles

Targeting Mitochondrial Factor Smac/DIABLO as Therapy for Multiple Myeloma (MM).

Dharminder Chauhan, Ph.D, Guilan Li, M.S, Teru Hideshima, Ph.D, Klaus Podar, Ph.D, Pierfrancesco Tassone, M.D., Paola E. Neri, M.D., Constantine Mitsiades, Ph.D, Nicholas Mitsiades, M.D., Noopur Raje, M.D., Shaji Kumar, M.D., Robert Schlossman, M.D., Sushil Sharma, M.D., Nikhil Munshi, M.D., Leigh Zawel, Ph.D, Kenneth C. Anderson, M.D.
Journal: Blood
Blood (2004) 104 (11): 764.
https://doi.org/10.1182/blood.V104.11.764.764
Published: 2004
Journal Articles

Enhanced Cytotoxicity of Monoclonal Antibody SGN-40 and Immunomodulatory Drug IMiD3 Against Human Multiple Myeloma.

Yu-Tzu Tai, Ph.D., Laurence Catley, M.D., Xian-Feng Li, M.S., Makoto Hamasaki, M.D., Ph.D., Klaus Podar, M.D., Ph.D., Teru Hideshima, M.D., Ph.D., Dharminder Chauhan, Ph.D., Robert Schlossman, M.D., Paul Richardson, M.D., Steven P. Streon, M.D., Ph.D., Nikhil C. Munshi, M.D., Kenneth C. Anderson, M.D.
Journal: Blood
Blood (2004) 104 (11): 1498.
https://doi.org/10.1182/blood.V104.11.1498.1498
Published: 2004